Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11489442 | 0.78 | RIPK1 (0.33) | — | |
| SCHEMBL6060603 | 0.77 | FFAR1 (0.31) | — | |
| SCHEMBL11253599 | 0.74 | — | — | |
| SCHEMBL21499420 | 0.74 | — | — | |
| SCHEMBL17751080 | 0.74 | — | — | |
| SCHEMBL24786207 | 0.74 | GRM4 (0.31) | — | |
| SCHEMBL598014 | 0.72 | TSHR (0.33) | ALDH1A1 | |
| SCHEMBL5368748 | 0.72 | SMN1; SMN2 (0.38) | ALDH1A1 | |
| SCHEMBL11569123 | 0.72 | — | — | |
| SCHEMBL13741585 | 0.70 | NFKB1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697693-B2 | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-07-11 | — | — | US | disclosed |
| US-20210347918-A1 | NITRIC OXIDE-RELEASING ALGINATES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347918-A1 | NITRIC OXIDE-RELEASING ALGINATES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | NOS1, NOS2, NOS3 | ALDH1A1 667/4885 |
| US-11697693-B2 | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto | NOS1, NOS2, NOS3 | ALDH1A1 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.